Marc Semigran
Chief Development Officer · Edgewise Therapeutics, Inc.
- 2024
- Dec 27, 2024
- 1
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Marc Semigran files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Alan J. Russell - $10.25M in EWTX purchases and sales in the last 12 months
- Joanne M. Donovan - $4.62M in EWTX purchases and sales in the last 12 months
- Badreddin Edris - $3.40M in EWTX purchases and sales in the last 12 months
- Kevin Koch - $785K in EWTX purchases and sales in the last 12 months
- Behrad Derakhshan - $223K in EWTX purchases and sales in the last 12 months
- John R. Moore - $220K in EWTX purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Marc Semigran?
Marc Semigran is a corporate insider, tracked as Chief Development Officer of Edgewise Therapeutics, Inc. (EWTX). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Marc Semigran last file a Form 4?
The only primary Form 4 on record is dated 27 December 2024.
Has Marc Semigran been buying or selling stock?
Recorded transactions: 0 open-market purchases and 2 open-market sales ($882K) across all tracked filings.
